ERYTECH PHARMA - SPON ADR (ERYP) Stock Analyst Earnings Estimates
NASDAQ:ERYP - Nasdaq - US29604W1080 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.718M -29.62% | 4.18M 12.43% | 6.648M 59.04% | 21.067M 216.89% | 24.704M 17.26% | 1.53M -93.81% | 1.683M 10.00% | |
| EBITDA YoY % growth | -63.841M -6.65% | -51.138M 19.90% | -22.528M 55.95% | -27.54M -22.25% | 6.12M 122.22% | N/A | N/A | |
| EBIT YoY % growth | -68.832M -7.43% | -56.515M 17.89% | -27.147M 51.96% | -27.8M -2.41% | -11.863M 57.33% | -33.129M -179.26% | -33.712M -1.76% | |
| Operating Margin | -1,851.32% | -1,352.03% | -408.35% | -131.96% | -48.02% | -2,165.27% | -2,003.11% | |
| EPS YoY % growth | N/A -5.11% | N/A 17.43% | N/A 51.41% | -0.95 22.35% | -0.50 47.80% | N/A | N/A |
All data in EUR
| Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 57.45% | -0.19 -94.73% | -0.20 38.89% | -0.23 -38.89% |
| Revenue Q2Q % growth | 299.88K -44.36% | 320.28K -66.43% | 333.54K -28.88% | 380.46K -93.32% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.314M 49.55% | -6.734M 72.24% | -7.016M -26.02% | -7.997M -176.80% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 62.50% | -0.17 | % | |
| Q3 2022 Q2Q % growth | 38.98% | -0.33 | % | |
| Q2 2022 Q2Q % growth | -0.10 81.72% | -0.52 | 0.42 | 80.74% |
| Q4 2021 Q2Q % growth | 84.42% | -0.45 | % | |
| Q4 2020 Q2Q % growth | 10.54% | -2.86 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 5.694M 198.12% | 714K | 4.98M | 697.48% |
| Q3 2022 Q2Q % growth | 469K -69.35% | 2.55M | -2.081M | -81.61% |
| Q2 2022 Q2Q % growth | 954K -57.97% | 2.55M | -1.596M | -62.59% |
| Q1 2022 Q2Q % growth | 539K -62.57% | 2.55M | -2.011M | -78.86% |
| Q4 2021 Q2Q % growth | 1.91M 2.19% | 1.53M | 380K | 24.84% |
| Q3 2021 Q2Q % growth | 46.97% | 1.53M | % | |
| Q2 2021 Q2Q % growth | 2.27M 22.77% | % | ||
| Q4 2020 Q2Q % growth | 1.869M -19.37% | 19.792M | -17.923M | -90.56% |
| Q3 2020 Q2Q % growth | 1.041M 13.65% | % | ||
| Q2 2020 Q2Q % growth | 1.849M -37.64% | % | ||
| Q4 2019 Q2Q % growth | 2.318M | 6.428M | -4.11M | -63.94% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 9.09% | 0% | 9.09% |
| Revenue | 0% | 0% | 0% | 0% |